CA-AG v. Allergan

Allergan allegedly deceptively marketed opioids by downplaying the risk of addiction, overstating their benefits, and encouraging doctors to treat patients showing signs of addiction by prescribing them more opioids; and failed to maintain effective controls to prevent diversion of opioids, according to CA-AG.

Summary generated from official California Attorney General press release